Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Predicting cognitive decline and conversion to Alzheimer's disease in older adults using the NAB List Learning test.

Gavett BE, Ozonoff A, Doktor V, Palmisano J, Nair AK, Green RC, Jefferson AL, Stern RA.

J Int Neuropsychol Soc. 2010 Jul;16(4):651-60. doi: 10.1017/S1355617710000421. Epub 2010 Apr 7.

2.

Diagnostic utility of the NAB List Learning test in Alzheimer's disease and amnestic mild cognitive impairment.

Gavett BE, Poon SJ, Ozonoff A, Jefferson AL, Nair AK, Green RC, Stern RA.

J Int Neuropsychol Soc. 2009 Jan;15(1):121-9. doi: 10.1017/S1355617708090176.

3.

Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment.

Tabert MH, Manly JJ, Liu X, Pelton GH, Rosenblum S, Jacobs M, Zamora D, Goodkind M, Bell K, Stern Y, Devanand DP.

Arch Gen Psychiatry. 2006 Aug;63(8):916-24.

PMID:
16894068
4.

False-Positive Error Rates for Reliable Digit Span and Auditory Verbal Learning Test Performance Validity Measures in Amnestic Mild Cognitive Impairment and Early Alzheimer Disease.

Loring DW, Goldstein FC, Chen C, Drane DL, Lah JJ, Zhao L, Larrabee GJ; Alzheimer's Disease Neuroimaging Initiative..

Arch Clin Neuropsychol. 2016 Jun;31(4):313-31. doi: 10.1093/arclin/acw014. Epub 2016 Apr 15.

PMID:
27084732
5.

[Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].

Robert PH, Schuck S, Dubois B, Lépine JP, Gallarda T, Olié JP, Goni S, Troy S.

Encephale. 2003 May-Jun;29(3 Pt 1):266-72. French.

PMID:
12876552
6.

Cases with mild cognitive impairment and Alzheimer's disease fail to benefit from repeated exposure to episodic memory tests as compared with controls.

Schrijnemaekers AM, de Jager CA, Hogervorst E, Budge MM.

J Clin Exp Neuropsychol. 2006 Apr;28(3):438-55.

PMID:
16618630
7.

CERAD neuropsychological compound scores are accurate in detecting prodromal alzheimer's disease: a prospective AddNeuroMed study.

Paajanen T, Hänninen T, Tunnard C, Hallikainen M, Mecocci P, Sobow T, Tsolaki M, Vellas B, Lovestone S, Soininen H.

J Alzheimers Dis. 2014;39(3):679-90. doi: 10.3233/JAD-122110.

PMID:
24246420
8.

Brain substrates of learning and retention in mild cognitive impairment diagnosis and progression to Alzheimer's disease.

Chang YL, Bondi MW, Fennema-Notestine C, McEvoy LK, Hagler DJ Jr, Jacobson MW, Dale AM; Alzheimer's Disease Neuroimaging Initiative..

Neuropsychologia. 2010 Apr;48(5):1237-47. doi: 10.1016/j.neuropsychologia.2009.12.024. Epub 2009 Dec 23.

9.

Screening of mild cognitive impairment in Chinese older adults--a multistage validation of the Chinese abbreviated mild cognitive impairment test.

Lam LC, Tam CW, Lui VW, Chan WC, Chan SS, Chiu HF, Leung T, Tham MK, Ho KS, Chan WM.

Neuroepidemiology. 2008;30(1):6-12. doi: 10.1159/000113300. Epub 2008 Jan 17.

PMID:
18204291
10.

Comparison of the short test of mental status and the mini-mental state examination in mild cognitive impairment.

Tang-Wai DF, Knopman DS, Geda YE, Edland SD, Smith GE, Ivnik RJ, Tangalos EG, Boeve BF, Petersen RC.

Arch Neurol. 2003 Dec;60(12):1777-81.

PMID:
14676056
11.

Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease.

Devanand DP, Pradhaban G, Liu X, Khandji A, De Santi S, Segal S, Rusinek H, Pelton GH, Honig LS, Mayeux R, Stern Y, Tabert MH, de Leon MJ.

Neurology. 2007 Mar 13;68(11):828-36.

PMID:
17353470
12.

The impact of anxiety on conversion from mild cognitive impairment to Alzheimer's disease.

Devier DJ, Pelton GH, Tabert MH, Liu X, Cuasay K, Eisenstadt R, Marder K, Stern Y, Devanand DP.

Int J Geriatr Psychiatry. 2009 Dec;24(12):1335-42. doi: 10.1002/gps.2263.

13.

Entorhinal cortex thickness predicts cognitive decline in Alzheimer's disease.

Velayudhan L, Proitsi P, Westman E, Muehlboeck JS, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Soininen H, Spenger C, Hodges A, Powell J, Lovestone S, Simmons A; dNeuroMed Consortium..

J Alzheimers Dis. 2013;33(3):755-66. doi: 10.3233/JAD-2012-121408.

PMID:
23047370
14.

Cognitive decline is faster in Lewy body variant than in Alzheimer's disease.

Olichney JM, Galasko D, Salmon DP, Hofstetter CR, Hansen LA, Katzman R, Thal LJ.

Neurology. 1998 Aug;51(2):351-7.

PMID:
9710002
15.

CERAD test performances in amnestic mild cognitive impairment and Alzheimer's disease.

Karrasch M, Sinervä E, Grönholm P, Rinne J, Laine M.

Acta Neurol Scand. 2005 Mar;111(3):172-9.

PMID:
15691286
16.
17.

Early detection of Alzheimer's disease with a total score of the German CERAD.

Ehrensperger MM, Berres M, Taylor KI, Monsch AU.

J Int Neuropsychol Soc. 2010 Sep;16(5):910-20. doi: 10.1017/S1355617710000822. Epub 2010 Aug 4.

PMID:
20682088
18.

Rates of hippocampal atrophy correlate with change in clinical status in aging and AD.

Jack CR Jr, Petersen RC, Xu Y, O'Brien PC, Smith GE, Ivnik RJ, Boeve BF, Tangalos EG, Kokmen E.

Neurology. 2000 Aug 22;55(4):484-89.

19.

Detection of MCI in the clinic: evaluation of the sensitivity and specificity of a computerised test battery, the Hopkins Verbal Learning Test and the MMSE.

de Jager CA, Schrijnemaekers AC, Honey TE, Budge MM.

Age Ageing. 2009 Jul;38(4):455-60. doi: 10.1093/ageing/afp068. Epub 2009 May 19.

PMID:
19454402
20.

A total score for the CERAD neuropsychological battery.

Chandler MJ, Lacritz LH, Hynan LS, Barnard HD, Allen G, Deschner M, Weiner MF, Cullum CM.

Neurology. 2005 Jul 12;65(1):102-6.

PMID:
16009893

Supplemental Content

Support Center